Thierry Pieton - 03 Mar 2025 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & Chief Financial Officer
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
03 Mar 2025
Net transactions value
+$2,900,102
Form type
4
Filing time
05 Mar 2025, 17:22:08 UTC
Next filing
30 Jul 2025
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Award $400,021 +4,242 $94.30 4,242 03 Mar 2025 Direct F1
transaction MDT Ordinary Shares Award $2,500,082 +26,512 +625% $94.30 30,754 03 Mar 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Performance Share Unit Award $0 +10,605 $0.000000 10,605 03 Mar 2025 Performance Share Units 10,605 Direct F3, F4, F5
transaction MDT Stock Option (Right to Buy) Award $0 +29,574 $0.000000 29,574 03 Mar 2025 Ordinary Shares 29,574 $94.30 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
F2 Represents restricted stock units that vest in three annual installments beginning one year from the date of grant.
F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F4 Vests on April 30, 2027.
F5 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 10,605 shares will be issued. If maximum performance metrics are achieved, 21,210 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F6 The options are exercisable in four annual installments beginning one year from the date of grant.